Skip to content

Monitoring the progress of pregnancy and prediciton of pregnangcy outcome: targeting the placenta

Monitoring the progress of pregnancy and prediciton of pregnangcy outcome: targeting the placenta

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026937
Enrollment
Unknown
Registered
2019-10-26
Start date
2019-10-26
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Dysfunction

Interventions

Gold Standard:Clinical outcome
placenta&#32
CT&#32
angiography,&#32
corrosion&#32
casting,&#32
peripheral&#32
blood&#32
acid&#32
and&#32
biomarkers

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Singleton live-pregnancy women with gestational age between 20-42 weeks. All participants were devided into two groups: Non-dysfunctional placenta group, such as suspected fetal malformation and placenta previa, etc; dysfunctional placenta group, such as preeclampsia and fetal growth restriction. 2. Plan to deliver in participant hospitals. 5. Able to sign and understand the informed consent

Exclusion criteria

Exclusion criteria: 1. Emergenct condition for terminating pregnancy, such as eclampsia and fetal distress; 2. Combined with severe comorbidity that indicated C-section; 3. With contraindication for MRI scan.

Design outcomes

Primary

MeasureTime frame
placenta function;SEN, SPE, ACC, AUC of ROC;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactLiu Ping

Nanfang Hospital, Southern Medical University

lpivy@126.com+86 13725263091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026